Skip to content
Head to head

Medpace vs Thermo Fisher Scientific

Side-by-side on the measures that matter, with a plain-English read. Full detail: MEDP · TMO

Updated moments ago

1-year performance, rebased to 100

MEDP +4.2%TMO +18.4%
Thermo Fisher Scientific edges it on the scoreable measures. Thermo Fisher Scientific has the highest Quant Rating (61); Thermo Fisher Scientific has done best over the past year (+17%); Thermo Fisher Scientific pays the highest dividend yield.
MEDPTMO
Snapshot
SectorDiagnostics & ResearchDiagnostics & Research
Last price610.54669.54
Change today-3.70%-2.79%
1-year return+4.2%+17.2%
Market cap$17.08B$248.08B
52-week range373.00 – 693.97434.50 – 727.56
Valuation
P/E (TTM)33.9035.31
P/E percentile, own 5-yr range60th89th
P/B29.204.53
Dividend yield0.00%0.27%
Profitability & growth
EPS (TTM)15.2817.74
Net profit (TTM)$427.41M$6.57B
Revenue (TTM)$2.84B$47.35B
Provider revenue period date2026-09-292026-09-25
Revenue growth (YoY)+8.5%+9.1%
Gross margin29.1%41.1%
Operating margin21.4%18.7%
Net margin18.2%14.9%
Free cash flow (TTM)$667.63M$7.60B
Provider cash-flow period date2026-09-292026-09-25
Ownership & sentiment
Institutional ownership84.8%94.1%
Insider activity (12mo)18 buy / 29 sell20 buy / 30 sell
Short interest (% of float)4.9%1.3%
Analyst consensus38% buy / 62% hold (8)88% buy / 12% hold (16)
Analyst price target$691 (+13%)$778 (+16%)
StockVane view
StockVane Quant RatingC (44)C (61)
Company
Employees6,200125,000
Founded19921956

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.